Intelligent Bio Solutions (INBS) Acquisitions (2023)

Intelligent Bio Solutions (INBS) recorded quarterly Acquisitions of $189019.0 in Q2 2023, down 46.94% quarter-over-quarter from $356231.0 in Q1 2023.

Intelligent Bio Solutions (INBS) Acquisitions (2023) Analysis & Trends

Intelligent Bio Solutions' Acquisitions history runs 1 years deep, the most recent figure standing at $189019.0 for Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn -
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 22.00 Mn
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn -
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn -
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn -
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn 2.30 Bn
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn -
10 Intelligent Bio Solutions 12.89 Mn 11.69 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 189,019.00
Mar 31, 2023 356,231.00